Warfarin-induced leukocytoclastic vasculitis

Skin reactions associated with oral coumarin-derived anticoagulants are an uncommon occurrence. Leukocytoclastic vasculitis (LV) is primarily a cutaneous small vessel vasculitis, though systemic involvement may be encountered. We report 4 patients with late-onset LV probably due to warfarin. All 4 p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cutis (New York, N.Y.) N.Y.), 2005-06, Vol.75 (6), p.329
Hauptverfasser: Yaghoubian, Bahareh, Ngo, Binh, Mak, May, Ostrzega, Enrique, Tesoro, Jane, Mitani, Gladys H Moriguchi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 329
container_title Cutis (New York, N.Y.)
container_volume 75
creator Yaghoubian, Bahareh
Ngo, Binh
Mak, May
Ostrzega, Enrique
Tesoro, Jane
Mitani, Gladys H Moriguchi
description Skin reactions associated with oral coumarin-derived anticoagulants are an uncommon occurrence. Leukocytoclastic vasculitis (LV) is primarily a cutaneous small vessel vasculitis, though systemic involvement may be encountered. We report 4 patients with late-onset LV probably due to warfarin. All 4 patients presented with skin eruptions that developed after receiving warfarin for several years. The results of skin lesion biopsies were available in 3 patients, confirming LV Cutaneous lesions resolved in all patients after warfarin was discontinued. In 2 of the 4 patients, rechallenge with warfarin led to recurrence of the lesions. LV may be a late-onset adverse reaction associated with warfarin therapy.
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_16047871</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16047871</sourcerecordid><originalsourceid>FETCH-LOGICAL-p209t-19ed5078069f6d2b2f6290af3b13039fce3a1f38f04d2047dd0ed89de29fb903</originalsourceid><addsrcrecordid>eNo1jsuKAjEQAHNwUVf9BfEDDHSSMZk-irgPEPYi7FEy6TRERx0mM4J_v8LqqahLUQMxBlBKFsrqkXjP-fhQ1M4NxUhZKFzp1Fgsf33Lvk0XmS7Uh0iLOvana7h311D73KWwuPkc-jp1KU_FG_s6x9mTE7H_2O43X3L38_m9We9kowE7qTDSClwJFtmSrjRbjeDZVMqAQQ7ReMWmZChIP0aIIFKJFDVyhWAmYv6fbfrqHOnQtOns2_vhdW3-AIlhPWc</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Warfarin-induced leukocytoclastic vasculitis</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Yaghoubian, Bahareh ; Ngo, Binh ; Mak, May ; Ostrzega, Enrique ; Tesoro, Jane ; Mitani, Gladys H Moriguchi</creator><creatorcontrib>Yaghoubian, Bahareh ; Ngo, Binh ; Mak, May ; Ostrzega, Enrique ; Tesoro, Jane ; Mitani, Gladys H Moriguchi</creatorcontrib><description>Skin reactions associated with oral coumarin-derived anticoagulants are an uncommon occurrence. Leukocytoclastic vasculitis (LV) is primarily a cutaneous small vessel vasculitis, though systemic involvement may be encountered. We report 4 patients with late-onset LV probably due to warfarin. All 4 patients presented with skin eruptions that developed after receiving warfarin for several years. The results of skin lesion biopsies were available in 3 patients, confirming LV Cutaneous lesions resolved in all patients after warfarin was discontinued. In 2 of the 4 patients, rechallenge with warfarin led to recurrence of the lesions. LV may be a late-onset adverse reaction associated with warfarin therapy.</description><identifier>ISSN: 0011-4162</identifier><identifier>PMID: 16047871</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Anticoagulants - adverse effects ; Female ; Humans ; Male ; Middle Aged ; Vasculitis, Leukocytoclastic, Cutaneous - chemically induced ; Warfarin - adverse effects</subject><ispartof>Cutis (New York, N.Y.), 2005-06, Vol.75 (6), p.329</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16047871$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yaghoubian, Bahareh</creatorcontrib><creatorcontrib>Ngo, Binh</creatorcontrib><creatorcontrib>Mak, May</creatorcontrib><creatorcontrib>Ostrzega, Enrique</creatorcontrib><creatorcontrib>Tesoro, Jane</creatorcontrib><creatorcontrib>Mitani, Gladys H Moriguchi</creatorcontrib><title>Warfarin-induced leukocytoclastic vasculitis</title><title>Cutis (New York, N.Y.)</title><addtitle>Cutis</addtitle><description>Skin reactions associated with oral coumarin-derived anticoagulants are an uncommon occurrence. Leukocytoclastic vasculitis (LV) is primarily a cutaneous small vessel vasculitis, though systemic involvement may be encountered. We report 4 patients with late-onset LV probably due to warfarin. All 4 patients presented with skin eruptions that developed after receiving warfarin for several years. The results of skin lesion biopsies were available in 3 patients, confirming LV Cutaneous lesions resolved in all patients after warfarin was discontinued. In 2 of the 4 patients, rechallenge with warfarin led to recurrence of the lesions. LV may be a late-onset adverse reaction associated with warfarin therapy.</description><subject>Adult</subject><subject>Anticoagulants - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Vasculitis, Leukocytoclastic, Cutaneous - chemically induced</subject><subject>Warfarin - adverse effects</subject><issn>0011-4162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jsuKAjEQAHNwUVf9BfEDDHSSMZk-irgPEPYi7FEy6TRERx0mM4J_v8LqqahLUQMxBlBKFsrqkXjP-fhQ1M4NxUhZKFzp1Fgsf33Lvk0XmS7Uh0iLOvana7h311D73KWwuPkc-jp1KU_FG_s6x9mTE7H_2O43X3L38_m9We9kowE7qTDSClwJFtmSrjRbjeDZVMqAQQ7ReMWmZChIP0aIIFKJFDVyhWAmYv6fbfrqHOnQtOns2_vhdW3-AIlhPWc</recordid><startdate>200506</startdate><enddate>200506</enddate><creator>Yaghoubian, Bahareh</creator><creator>Ngo, Binh</creator><creator>Mak, May</creator><creator>Ostrzega, Enrique</creator><creator>Tesoro, Jane</creator><creator>Mitani, Gladys H Moriguchi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200506</creationdate><title>Warfarin-induced leukocytoclastic vasculitis</title><author>Yaghoubian, Bahareh ; Ngo, Binh ; Mak, May ; Ostrzega, Enrique ; Tesoro, Jane ; Mitani, Gladys H Moriguchi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p209t-19ed5078069f6d2b2f6290af3b13039fce3a1f38f04d2047dd0ed89de29fb903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Anticoagulants - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Vasculitis, Leukocytoclastic, Cutaneous - chemically induced</topic><topic>Warfarin - adverse effects</topic><toplevel>online_resources</toplevel><creatorcontrib>Yaghoubian, Bahareh</creatorcontrib><creatorcontrib>Ngo, Binh</creatorcontrib><creatorcontrib>Mak, May</creatorcontrib><creatorcontrib>Ostrzega, Enrique</creatorcontrib><creatorcontrib>Tesoro, Jane</creatorcontrib><creatorcontrib>Mitani, Gladys H Moriguchi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cutis (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yaghoubian, Bahareh</au><au>Ngo, Binh</au><au>Mak, May</au><au>Ostrzega, Enrique</au><au>Tesoro, Jane</au><au>Mitani, Gladys H Moriguchi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Warfarin-induced leukocytoclastic vasculitis</atitle><jtitle>Cutis (New York, N.Y.)</jtitle><addtitle>Cutis</addtitle><date>2005-06</date><risdate>2005</risdate><volume>75</volume><issue>6</issue><spage>329</spage><pages>329-</pages><issn>0011-4162</issn><abstract>Skin reactions associated with oral coumarin-derived anticoagulants are an uncommon occurrence. Leukocytoclastic vasculitis (LV) is primarily a cutaneous small vessel vasculitis, though systemic involvement may be encountered. We report 4 patients with late-onset LV probably due to warfarin. All 4 patients presented with skin eruptions that developed after receiving warfarin for several years. The results of skin lesion biopsies were available in 3 patients, confirming LV Cutaneous lesions resolved in all patients after warfarin was discontinued. In 2 of the 4 patients, rechallenge with warfarin led to recurrence of the lesions. LV may be a late-onset adverse reaction associated with warfarin therapy.</abstract><cop>United States</cop><pmid>16047871</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0011-4162
ispartof Cutis (New York, N.Y.), 2005-06, Vol.75 (6), p.329
issn 0011-4162
language eng
recordid cdi_pubmed_primary_16047871
source MEDLINE; EZB Electronic Journals Library
subjects Adult
Anticoagulants - adverse effects
Female
Humans
Male
Middle Aged
Vasculitis, Leukocytoclastic, Cutaneous - chemically induced
Warfarin - adverse effects
title Warfarin-induced leukocytoclastic vasculitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A11%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Warfarin-induced%20leukocytoclastic%20vasculitis&rft.jtitle=Cutis%20(New%20York,%20N.Y.)&rft.au=Yaghoubian,%20Bahareh&rft.date=2005-06&rft.volume=75&rft.issue=6&rft.spage=329&rft.pages=329-&rft.issn=0011-4162&rft_id=info:doi/&rft_dat=%3Cpubmed%3E16047871%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16047871&rfr_iscdi=true